Skip to main content
. Author manuscript; available in PMC: 2024 Mar 7.
Published in final edited form as: J Pain Symptom Manage. 2018 May 30;56(3):352–362. doi: 10.1016/j.jpainsymman.2018.05.019

Table 5.

Multiple Logistic Regression Analysis Predicting Nausea Group Membership (n = 1035)

Predictor Odds Ratio 95% CI p-value
Education (years) 0.93 0.89, 0.98 0.003
Child care responsibilities 1.42 1.03, 1.97 0.032
Karnofsky Performance Status score 0.96 0.95, 0.98 < 0.001
CES-D score 1.03 1.00,1.05 0.026
General Sleep Disturbance Scale score 1.01 1.00,1.02 0.011
Evening fatigue score (LFS) 1.12 1.04,1.20 0.003
Perceived Stress Scale score 0.97 0.95, 0.99 0.015
IES-R Intrusion subscale score 1.35 1.04, 1.75 0.026
CTX cycle length 0.001
 21 day cycle vs 14 day cycle 0.58 0.44, 0.77 < 0.001
 28 day cycle vs 14 day cycle 0.91 0.52, 1.61 0.754
 21 day cycle vs 28 day cycle 0.64 0.37, 1.11 0.110
Antiemetic regimen 0.019
 Steroid alone or serotonin receptor antagonist alone vs None 0.88 0.48, 1.61 0.675
 Serotonin receptor antagonist and steroid vs None 1.52 0.87, 2.67 0.141
 NK-1 receptor antagonist and two other antiemetics vs None 1.37 0.75, 2.49 0.307
 Serotonin receptor antagonist and steroid vs Steroid alone or serotonin receptor antagonist alone 1.73 1.21, 2.49 0.003
 Steroid alone or serotonin receptor antagonist alone vs NK-1 receptor antagonist and two other antiemetics 0.64 0.42, 0.97 0.037
 Serotonin receptor antagonist and steroid vs NK-1 receptor antagonist and two other antiemetics 1.12 0.80, 1.56 0.529
Overall model fit: df = 13, X2 = 189.99, p < 0.001

Abbreviations: CES-D = Center for Epidemiological Studies-Depression Scale, CI = confidence interval, CTX = chemotherapy, IES-R = Impact of Event Scale-Revised, LFS = Lee Fatigue Scale, NK-1 = neurokinin-1